---
title: "Top Premarket Gainers"
date: "2025-02-11 20:35:02"
summary: "Lipella Pharmaceuticals shares were up 57% pre-bell Tuesday after the company said its treatment candidate for oral lichen planus showed \"clinically meaningful\" reductions in pain, ulceration and inflammation \"across all key metrics\" in a phase 2a trial. Alliance Entertainment stock was 32% higher after a 1.7% gain on Monday. SelectQuote..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Lipella Pharmaceuticals shares were up 57% pre-bell Tuesday after the company said its treatment candidate for oral lichen planus showed "clinically meaningful" reductions in pain, ulceration and inflammation "across all key metrics" in a phase 2a trial.

Alliance Entertainment stock was 32% higher after a 1.7% gain on Monday.

SelectQuote shares were up 27%, a day after the company said it signed an agreement for $350 million in investment from funds managed by Bain Capital, Morgan Stanley (MS) Private Credit, and Newlight Partners.

Lee Enterprises stock was 23% higher, reversing from Monday's 4.5% fall.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250211:A3314345:0/)
